Abstract:Cerebral ischemia caused by a blood supply deficiency triggers various pathophysiological changes. Many factors are involved in the development of ischemia injury. For example the longer ischemia time is more prone to ischemia injury, and the brain is very susceptible to energy-depriving injuries due to its characteristics of low fuel reserves, high aerobic metabolism and low concentrations of oxygen radicals–scavenging enzymes. Rapid reperfusion is the most effective treatment for ischemia, minimizing both structural and functional injuries [1]. Many signaling molecules have been postulated to contribute to ischemia, including both excitotoxicity and oxidative stress [2]. Glutamate emerges as the major excitatory neurotransmitter stimulating energy production in the central nervous system (CNS) that is involved in many neurophysiological functions. A disruption of its homeostasis can damage neurons, which may eventually lead to neural cell death [3]. This neuropathological process, designated excitotoxicity, can induce degeneration of neural cells following an excessive action on its specific ionotropic glutamate receptor, N-methyl-d-aspartate (NMDA) [4]. The activation of NMDA receptor (NMDAR) usually triggers intracellular transduction pathways associated with changes in [Ca]i levels, resulting in neural Ca influx and a cascade of events involving free radical production, and mitochondrial dysfunction can mediate excitotoxicity, resulting in damage to the cell membrane, cytoskeleton, and DNA [5]. Thus, modulating the glutamate pathway is a new concept and therapeutic option to attenuate cerebral ischemia [6]. Oxysophoridine (OSR) is an alkaloid extracted from Siphocampylus verticillatus. Its chemical structure is made of two piperidine rings. The report in the literature has shown that the hydroalcoholic extract of Siphocampylus verticillatus has significant and longlasting antinociception when assessed against both neurogenic and inflammatory models of nociception in mice [7]. Previous work in our laboratory has demonstrated that OSR has an antinociceptive effect and such protection may be mediated by GABA and GABAA receptor up-regulation after OSR pretreatment [8]. In the present study, we tested the hypothesis that the protective effect of OSR was through regulating the glutamate pathway. The hippocampal neurons are cultured using primary rat cells [6]. Sprague-Dawley rats were purchased from the Animal Center of Ningxia medical university, Ningxia, China. All procedures were approved by the Institutional Ethics Committee, and we analyzed the neuroprotective effect of OSR (Ningxia Institute of Materia Medica, Ningxia, China). The purity of OSR was determined to be 99% on the hippocampal neurons sustained oxygen– glucose deprivation/reperfusion (OGD/Rep) in vitro [9]. The cells were randomly divided into six groups: control group; vehicle group (injury by OGD 2 h/Rep 24 h); positive nimodipine control group (12 lM NIM), and different OSR dosage group (5, 20, 80 lM OSR). All the data obtained in the experiments were expressed as mean standard deviation (SD). A one-way analysis of variance (ANOVA) was used to compare the means of six groups. The Student Newman–Keuls’ (SNK)/least significant difference (LSD) test was performed to compare all pair means. All statistical analyses were run with the SPSS 16.0 statistical software package (SPSS, Chicago, IL, USA). P values of <0.05 and 0.01 were considered statistically significant.

Anti-inflammation Effects of Oxysophoridine on Cerebral Ischemia–Reperfusion Injury in Mice

Oxysophoridine Protects Against Focal Cerebral Ischemic Injury by Inhibiting Oxidative Stress and Apoptosis in Mice

Effects of Oxysophoridine on the Level of NO and NOS in Brain Tissue of Mice with Cerebral Ischemia and Reperfusion Injury

Protective effects of oxysophoridine on acute cerebral ischemia injury in mice

Protective Effect of Oxysophoridine on Cerebral Ischemia/reperfusion Injury in Mice

Effects of Oxysophoridine on Amino Acids after Cerebral Ischemic Injury in Mice

Effects of oxysophoridine on NMDA NR1 expression in the brain tissue of mice with cerebral ischemia and reperfusion injury

Anti-apoptotic and neuroprotective effects of oxysophoridine on cerebral ischemia both in vivo and in vitro

Effects Of Oxysophoridine On Rat Hippocampal Neurons Sustained Oxygen-Glucose Deprivation And Reperfusion

Effect of Oxysophoridine on Expression of TNF-α and COX-2 in Carbon Tetrachloride Induced Acute Liver Injury in Mice

Oxysophoridine inhibits oxidative stress and inflammation in hepatic fibrosis via regulating Nrf2 and NF-κB pathways

Neuroprotective Effects of Oxymatrine Against Excitotoxicity Partially Through Down-Regulation of NR2B-containing NMDA Receptors.

Oxysophocarpine protects airway epithelial cells against inflammation and apoptosis by inhibiting miR-155 expression

Neuroprotective Effect of Oxysophocarpine by Modulation of MAPK Pathway in Rat Hippocampal Neurons Subject to Oxygen–Glucose Deprivation and Reperfusion

Effects of Oxysophoridine on Glu and GABA Immuno-Reaction Positive Neurons in Cortex and Hippocampus of Rats

[Protective Effects and Mechanisms of OSR on Primary Cultured Hippocampus Neurons Subjected to Anoxic Injury in Neonatal Rat].

Orexin-A alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-κB and MAPK signaling pathways in cerebral ischemia/reperfusion injury

Neuroprotective effects of oxysophocarpine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion

Oxysophoridine through intrathecal injection induces antinociception and increases the expression of the GABAA α 1 Receptor in the spinal cord of mice

Ovatodiolide protects ischemia-reperfusion-induced neuronal injury via microglial neuroinflammation via mediating SIRT1/NF-κB pathway

Oxysophocarpine Ameliorates Carrageenan-induced Inflammatory Pain via Inhibiting Expressions of Prostaglandin E2 and Cytokines in Mice